Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial
2018 ◽
Vol 144
(4)
◽
pp. 877-885
◽
Hans Tesch
◽
Oliver Stoetzer
◽
Thomas Decker
◽
Christian M. Kurbacher
◽
Frederik Marmé
◽
...
2021 ◽
Vol 0
(0)
◽
pp. 0-0
Hui-Qiang Zhang
◽
Jin-Mei Zhou
◽
Shao-Hua Zhang
◽
Li Bian
◽
Jin-Yi Xiao
◽
...
2020 ◽
Vol 23
(5)
◽
pp. 460
Siqi Liu
◽
Xin Sun
◽
Xiaohui Xu
◽
Fangcai Lin
2020 ◽
Vol 26
(3)
◽
pp. 368-375
Karen A. Gelmon
◽
Massimo Cristofanilli
◽
Hope S. Rugo
◽
Angela M. DeMichele
◽
Anil A. Joy
◽
...
2014 ◽
Vol 51
(3)
◽
pp. 272
◽
N Majid
◽
S Boutayeb
◽
H Errihani
James Signorovitch
◽
Jenny Wang
◽
Ruo-Ding Tan
◽
Darren Thomason
◽
Andrew Kageleiry
◽
...
HS Rugo
◽
P Kabos
◽
MN Dickler
◽
WJ John
◽
I Smith
◽
...
2017 ◽
Vol 20
(9)
◽
pp. A433
◽
R Hettle
◽
G Suri
◽
R Mistry
◽
D Chandiwana
◽
A Lee
Hope S. Rugo
◽
J. Thad Beck
◽
Guy Jerusalem
◽
Hans Wildiers
◽
Peter Kabos
◽
...
Gayathri Nagaraj
◽
Cynthia X. Ma
Close
Export Citation Format
Close
Share Document
Close